Abstract
Tyrosinase is constitutively expressed by normal melanocytes and melanoma cells. Both melanocytes and melanoma cells are proposed to differentiate from an early melanocyte precursor sharing most of their basic phenotypes. In these cells tyrosinase is transported through the secretory pathway to melanosomes, intracellular organelles specialized in melanin synthesis. Tyrosinase arrival in melanosomes initiates melanogenesis by catalyzing the first step of a cascade of oxidations, isomerical rearrangements and polymerizations starting with the oxidation of tyrosine to DOPA and ending with the formation of the insoluble polymer melanin.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aroca, P., Martinez-Liarte, J.H., Solano, F., Garcia-Borron, J.C., and Lozano, J.A., 1992, The action of glycosy-lases on dopachrome (2-carboxy-2,3-dihydroindole-5,6-quinone) tautomerase, Biochem J. 284:109–113.
Blackwood, M.A., Holmes, R., Synnestvedt, M., Young, M., George, C., Yang, H., Elder, D.E., Schuchter, L.M., Guerry, D., and Ganguly, A., 2002, Multiple primary melanoma revisited, Cancer. 94(8):2248–2255.
Brady, M.S., Eckels, D.D., Ree, S.Y., Schultheiss, K.E., and Lee, J.S., 1996, MHC class II-mediated antigen presentation by melanoma cells, J Immunother Emphasis Tumor Immunol. 19(6):387–397.
Brady, M.S., Lee, F., Petrie, H, Eckels, D.D., and Lee, J.S., 2000, CD4(+) T cells kill HLA-class-II-antigen-positive melanoma cells presenting peptide in vitro, Cancer Immunol Immunother. 48(11):621–626.
Branza-Nichita, N., Negroiu, G., Petrescu, A.J., Garman, E.F., Platt, F.M., Wormald, M.R., Dwek, R.A., and Petrescu, S.M., 2000, Mutations at critical N-glycosylation sites reduce tyrosinase activity by altering folding and quality control, J Biol Chem. 275(11):8169–8175.
Brichard, V.G., Herman, J., Van Pel, A., Wildmann, C., Gaugler, B., Wolfel, T., Boon, T., and Lethe, B., 1996, A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes, Eur J Immunol. 26(1):223–224.
Castelli, C., Tarsini, P., Mazzocchi, A., Rini, E, Rivoltini, L., Ravagnani, F., Gallino, F, Belli, F, and Parmiani, G., 1999, Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens, J Immunol. 162(3):1739–1748.
del Marmol, V., Beermann, F., 1996, Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett. 381:165–168.
Engelhard, V.H., Brickner, A.G., and Zarling, A.L., 2002, Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire, Mol Immunol. 39(3–4):127–137.
Goodwin, B.L., Xi, H., Tejiram, R., Eason, D.D., Ghosh, N., Wright, K.L., Nagarajan, U., Boss, J.M., and Blanck, G., 2001, Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines, Cell Growth Differ. 12(6):327–335.
Hearing, V.J. and Tsukamoto, K., 1991, Enzymatic control of pigmentation in mammals, FASEB J. 5:2902–2909.
Hearing, V.J., 1987, Mammalian monophenol monooxygenase (tyrosinase): purification, properties, and reactions catalyzed, Methods Enzymol. 142:154–165.
Halaban, R., Svedine, S., Cheng, E., Smicun, Y., Aron, R., and Hebert, D.N., 2000, Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism, Proc Natl Acad Sci USA. 23;97(11):5889–5894.
Halaban, R., Cheng, E., Zhang, Y., Moellmann, G., Hanlon, D., Michalak, M., Setaluri, V., and Hebert, D.N., 1997, Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells, Proc Natl Acad Sci USA. 94(12):6210–6215.
Helenius, A. and Aebi, M., 2001, Intracellular functions of N-linked glycans, Science. 291(5512):2364–2369.
Kang, X., Kawakami, Y., el-Gamil, M., Wang, R., Sakaguchi, K., Yannelli, J.R., Appella, E., Rosenberg, S.A., and Robbins, R.F., 1995, Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumorinfiltrating lymphocytes, J Immunol. 155(3):1343–1348.
Kawakami, Y., Robbins, P.F., Wang, X., Tupesis, J.P., Parkhurst, M.R., Kang, X., Sakaguchi, K., Appella, E., and Rosenberg, S.A., 1998, Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1,-A2, and-A3 alleles, J Immunol. 161(12):6985–6992.
Kittlesen, D.J., Thompson, L.W., Gulden, P.H., Skipper, J.C., Colella, T.A., Shabanowitz, J., Hunt, D.F., Engelhard, V.H., Slingluff, C.L., Jr, and Shabanowitz, J.A., 1998, Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development, J Immunol. 160(5):2099–2106.
Kobayashi, H., Kokubo, T., Sato, K., Kimura, S., Asano, K., Takahashi, H., Iizuka, H., Miyokawa, N., and Katagiri, M., 1998, CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase, Cancer Res. 58(2):296–301.
Kowarik, M., Kung, S., Martoglio, B., and Helenius, A., 2002, Protein folding during cotranslational translocation in the endoplasmic reticulum., Mol Cell. 10(4):769–778.
Lupetti, R., Pisarra, P., Verrecchia, A., Farina, C., Nicolini, G., Anichini, A., Bordignon, C., Sensi, M., Parmiani, G., and Traversari, C., 1998, Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage, J Exp Med. 188(6):1005–1016.
Molinari, M. and Helenius, A., 2000, Chaperone selection during glycoprotein translocation into the endoplasmic reticulum, Science. 288(5464):331–333.
Negroiu, G., Dwek, R.A., and Petrescu, S.M., 2000, Folding and maturation of tyrosinase-related protein-1 are regulated by the post-translational formation of disulfide bonds and by N-glycan processing, J Biol Chem. 275(41):32200–32207.
Negroiu, G., Branza-Nichita, N., Costin, G.E., Titu, H., Petrescu, A.J., Dwek, R.A., and Petrescu, S.M., 1999, Investigation of the intracellular transport of tyrosinase and tyrosinase related protein (TRP)-1. The effect of endoplasmic reticulum (ER)-glucosidases inhibition, Cell Mol Biol (Noisy-le-grand). 45(7):1001–1010.
Negroiu, G., Branza-Nichita, N., Petrescu, A.J., Dwek, R.A., and Petrescu, S.M., 1999, Protein specific N-glycosylation of tyrosinase and tyrosinase-related protein-1 in B16 mouse melanoma cells, Biochem J. 344(3):659–665.
Ohkura, T., Yamashita, K., Mishima, Y., and Kobata, A., 1984, Purification of hamster melanoma tyrosinases and structural studies of their asparagine-linked sugar chains, Arch Biochem Biophys. 235:63–77.
Parkhurst, M.R., Fitzgerald, E.B., Southwood, S., Sette, A., Rosenberg, S.A., and Kawakami, Y., 1998, Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2), Cancer Res. 58(21):4895–4901.
Petrescu, S.M., Branza-Nichita, N., Negroiu, G., Petrescu, A.J., and Dwek, R.A., 2000, Tyrosinase and glycoprotein folding: roles of chaperones that recognize glycans, Biochemistry. 39(18):5229–5237.
Petrescu, S.M., Petrescu, A.J., Titu, H.N., Dwek, R.A., and Platt, F.M., 1997, Inhibition of N-glycan processing in B16 melanoma cells results in inactivation of tyrosinase but does not prevent its transport to the melanosome, J Biol Chem. 272(25):15796–15803.
Prota, G. and Thomson, R.H., 1976, Melanin pigmentation in mammals, Endeavor. 35:32–38.
Roux, L. and Lloyd, K.O., 1986, Glycosylation characteristics of pigmentation-associated antigen (GP75): an intracellular glycoprotein of human melanocytes and malignant melanomas, Arch Biochem Biophys. 251:87–96.
Skipper, J.C., Hendrickson, R.C., Gulden, P.H., Brichard, V., Van Pel, A., Chen, Y., Shabanowitz, J., Wolfel, T, Slingluff, C.L., Jr, Boon, T., Hunt, D.F., and Engelhard, V.H., 1996, An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins, J Exp Med. 183(2):527–534.
Schrag, J.D., Procopio, D.O., Cygler, M., Thomas, D.Y., and Bergeron, J.J., 2003, Lectin control of protein folding and sorting in the secretory pathway, Trends Biochem Sci. 28(1):49–57.
Topalian, S.L., Gonzales, M.I., Parkhurst, M., Li, Y.F., Southwood, S., Sette, A., Rosenberg, S.A., and Robbins, P.F., 1996, Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes, J Exp Med. 183(5):1965–1971.
Toyofuku, K., Wada, I., Hirosaki, K., Park, J.S., Hori, Y., and Jimbow, K., 1999, Promotion of tyrosinase folding in COS 7 cells by calnexin. J Biochem. 125:82–89.
Ujvari, A., Aron, R., Eisenhaure, T., Cheng, E., Parag, H.A., Smicun, Y., Halaban, R., and Hebert, D.N., 2001, Translation rate of human tyrosinase determines its N-linked glycosylation level, J Biol Chem. 276(8):5924–5931.
Zapun, A., Petrescu, S.M., Rudd, P.M., Dwek, R.A., Thomas, D.Y., and Bergeron, J.J., 1997, Conformation-independent binding of monoglucosylated ribonuclease B to calnexin, Cell. 88(1):29–38.
van Vreeswijk, H., Ruiter, D.J., Brocker, E.B., Welvaart, K., and Ferrone, S., 1988, Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma, Invest Dermatol. 90(5):755–760.
Vijayasaradhi, S., Xu, Y., Bouchard, B., Houghton, A.N., Vijayasaradhi, S., Xu, Y., Bouchard, B., and Houghton, A.N., 1995, Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75, J Cell Biol. 130:807–820.
Wang, R.F., Parkhurst, M.R., Kawakami, Y., Robbins, P.F., and Rosenberg, S.A., 1996a, Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen, J Exp Med. 183(3):1131–1140.
Wang, R.F., Appella, E., Kawakami, Y., Kang, X., and Rosenberg, S.A., 1996b, Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes, J Exp Med. 184(6):2207–2216.
Wang, R.F., Johnston, S.L., Southwood, S., Sette, A., and Rosenberg, S.A., 1998, Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and-A33, J Immunol. 160(2):890–897.
Wolfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Buschenfelde, K.H., and Boon, T., 1994, Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes, Eur J Immunol. 24(3):759–764.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this paper
Cite this paper
Petrescu, S.M., Popescu, C.I., Petrescu, A.J., Dwek, R.A. (2003). The Glycosylation of Tyrosinase in Melanoma Cells and the Effect on Antigen Presentation. In: Axford, J.S. (eds) Glycobiology and Medicine. Advances in Experimental Medicine and Biology, vol 535. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0065-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0065-0_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4908-2
Online ISBN: 978-1-4615-0065-0
eBook Packages: Springer Book Archive